OM
Training
Internal Medicine Residency at Stanford University.
Education includes Yale.
Explore education and trainingResearch
22 attributed works, including 10 as first author. Explore the publications and documented research affiliations.
Explore researchEducation and training
Yale
Research
Publications
22 attributed works · 10 first author. Counts reflect resolved authorship and may be incomplete.
- 2026Therapeutic Benefit Ratings for FDA Breakthrough-Designated Devices.JAMA surgery0 citesPMID 41739483
- 2026Medical Device Regulation - Who Does the FDA Serve?JOURNAL OF LAW MEDICINE & ETHICSfirst author0 citesPMID 41879133
- 2025Voting Trends Among Otolaryngology-Head and Neck Surgery Trainees.Laryngoscope investigative otolaryngology0 citesPMID 39990818
- 2025Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement.JAMA health forumfirst author1 citesPMID 41296375
- 2025Characterization of studies considered and required under Medicare's coverage with evidence development program.Clinical trials (London, England)0 citesPMID 39921418
- 2025Assessing Medicare's Coverage With Evidence Development Program.Health affairs (Project Hope)1 citesPMID 39761464
- 2025Research Derived From Medicare's Coverage With Evidence Development Program.JAMA network open0 citesPMID 40232723
- 2024Medical Devices Applying for Outpatient Medicare Supplemental Payments.JAMA health forumfirst authorRCR 0.351 citesPMID 39546305
- 2024Medicare Local Coverage Determinations: Evidence Quality Is Stronger For Covered Indications.Health affairs (Project Hope)first authorRCR 0.131 citesPMID 39626147
- 2024Regulation and Payment of New Medical Technologies (Yale University dissertation)first author
- 2024HPR109 Evaluation of Evidence Informing Medicare's Coverage With Evidence Development Decision Updates
- 2023Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program.JAMA cardiologyfirst authorRCR 1.5314 citesPMID 37878306
- 2022Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study.BMJ (Clinical research ed.)first authorRCR 2.5021 citesPMID 35537738
- 2022New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence.Drug safetyfirst authorRCR 1.3115 citesPMID 35182362
- 2022Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016.JAMA internal medicineRCR 0.6010 citesPMID 36190713
- 2022Generating evidence during a pandemic: what's reliable?BMJ (Clinical research ed.)RCR 0.000 citesPMID 35577370
- 2021An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.Health affairs (Project Hope)RCR 1.6130 citesPMID 33211535
- 2021Direct-to-consumer personal genomic tests need better regulation.Nature medicinefirst authorRCR 0.264 citesPMID 34017136
- 2021Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020JAMA Network Openfirst authorRCR 0.112 citesPMID 33929526
- 2020Covid-19, Single-Sourced Diagnostic Tests, and Innovation PolicyJournal of Law and the BiosciencesRCR 0.123 citesPMID 32908672
Sources
Roster sources establish the listed training role. Additional education, career, and research sources are added as the profile is enriched.
Program context: Internal Medicine Residency